Get started

POX

$STX/USDT 2h (#Bybit) Rising wedge breakdown and retestStacks seems locally topped here and a retracement down to 100EMA would make sense. ⚡️⚡️ #STX/USDT ⚡️⚡️ Exchanges: ByBit USDT Signal Type: Regular (Short) Leverage: Isolated (3.0X) Amount: 5.0% Current Price: 0.94020 Entry Targets: 1) 0.95080 Take-Profit Targets: 1) 0.76145 Stop Targets: 1) 1.07745 Published By: @Zblaba $STX #STXUSDT #Stacks #PoX Risk/Reward= 1:1.5 Expected Profit= +59.7% Possible Loss= -40.0% www.stacks.co
Short
by TradingOn
NBY effective against Monkeypox ! 20X Upside Analyst Rating!!!NovaBay Pharmaceuticals, Inc. (NBY) owns Avenova, which is EPA listed as an effective disinfectant for monkeypox. On 5/20/2022 Ascendiant Capital Markets brokerage set a price target of $4.00 for NovaBay Pharmaceuticals, Inc. (NBY). The stock is now only 0.20usd. Before the pandemic news, on their last earnings, they mentioned that Avenova Spray unit sales increased 15% with record-high units sold through the OTC channel. NovaBay CEO: "we expect the majority of 2022 topline growth to come in the second half of this year." The stock had only insider buys recently, the average being $0.45. Only 10.976Mil MARKET CAP The falling wedge in the chart is a bullish sign. I think we can expect at least a reversal to the $0.64 resistance. Looking forward to read your opinion about it.
AMEX:NBYLong
by TopgOptions